Literature DB >> 468224

The pathology of noncirrhotic portal fibrosis: a review of 32 autopsy cases.

B K Aikat, S R Bhusnurmath, P N Chhuttani, S K Mitra, D V Dutta.   

Abstract

A wide spectrum of clinical and morphologic changes in 32 autopsy cases of noncirrhotic portal fibrosis have been described. The disease frequently occurs in younger patients with a long history of splenomegaly, usually with a history of hematemesis. Females are affected almost equally as often as males in contrast to cirrhosis. The patients tolerate the bleeding episodes well. Death is usually due to massive hemorrhage. The diagnosis is achieved through a process of exclusion. A critical analysis of hemodynamic data, a splenoportogram, liver function tests (particularly Bromsulphalein retention) and angiographic data is mandatory. Needle biopsy of the liver appears to have limited value in making the diagnosis. The gross anatomic findings vary from a nearly normal liver to gross nodularity, seen particularly on the posteroinferior surface. In some cases these nodules are seen to physically impede the portal blood flow and contribute to portal hypertension. Phlebosclerosis of the smaller radicles of the portal vein and irregular scarring are the outstanding morphologic features of the disease. These changes are usually associated with irregular dilatation of some of the larger intrahepatic branches of the portal vein as well as fibroelastosis with or without occluding or organizing thrombi in both intra- and extrahepatic branches of the portal vein. The changes in hepatic venous radicles are characterized by irregular sclerosis, which seems to contribute significantly toward postsinusoidal block in advanced cases. The probable mode of evolution is discussed.

Entities:  

Mesh:

Year:  1979        PMID: 468224     DOI: 10.1016/s0046-8177(79)80046-5

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  16 in total

1.  Expression of HLA-DR antigen on hepatic vascular endothelial cells in idiopathic portal hypertension.

Authors:  T Terada; Y Nakanuma; M Hoso; H Obata
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

Review 2.  Pathophysiology and epidemiology of portal hypertension.

Authors:  H Okumura; T Aramaki; Y Katsuta
Journal:  Drugs       Date:  1989       Impact factor: 9.546

Review 3.  Non-cirrhotic portal fibrosis.

Authors:  S K Sarin
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

4.  Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge.

Authors:  Umberto Vespasiani Gentilucci; Paolo Gallo; Giuseppe Perrone; Riccardo Del Vescovo; Giovanni Galati; Sandro Spataro; Chiara Mazzarelli; Adriano Pellicelli; Antonella Afeltra; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

5.  Idiopathic portal hypertension associated with cytotoxic drugs.

Authors:  P Shepherd; D J Harrison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

6.  Microvasculature in the small portal tracts in idiopathic portal hypertension. A morphological comparison with other hepatic diseases.

Authors:  T Terada; M Hoso; Y Nakanuma
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

7.  Non-cirrhotic portal fibrosis related end stage liver disease in adults: evaluation from a study on living donor liver transplant recipients.

Authors:  Sanjiv Saigal; Nabeen C Nayak; Deepali Jain; Vinay Kumaran; Ravi Mohanka; Neeraj Saraf; Amit Rastogi; Naimesh Mehta; Samiran Nundy; Arvinder Soin
Journal:  Hepatol Int       Date:  2011-01-12       Impact factor: 6.047

Review 8.  Noncirrhotic portal hypertension.

Authors:  Harshal Rajekar; Rakesh K Vasishta; Yogesh K Chawla; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

9.  Non-cirrhotic portal hypertension with hypoxaemia.

Authors:  C Babbs; T W Warnes; N Y Haboubi
Journal:  Gut       Date:  1988-01       Impact factor: 23.059

10.  Analysis of inherited thrombophilic mutations and natural anticoagulant deficiency in patients with idiopathic portal hypertension.

Authors:  Kadim Bayan; Yekta Tüzün; Serif Yilmaz; Naime Canoruc; Mehmet Dursun
Journal:  J Thromb Thrombolysis       Date:  2008-08-07       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.